title: Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathway.
abstract: The orphan nuclear receptor 4A (NR4A) family plays critical roles in the regulation of cell proliferation, differentiation, and survival in the cardiovascular system. However, the molecular mechanisms underlying the regulation of NR4A receptor expression and its role in pulmonary artery smooth muscle cell (PASMC) function remain unclear. Here, we investigated whether the NR4A family regulates PASMC proliferation, and if so, which mechanisms are involved. By using quantitative real-time RT-PCR, we showed that the orphan nuclear receptor Nur77 was the most abundant member of NR4A family expressed in rat PASMCs, as compared with the two other members, NOR-1 and Nurr1. In rat PASMCs, expression of Nur77 was robustly induced in response to several pathologic stimuli of pulmonary arterial hypertension (PAH), such as hypoxia, 5-hydroxytryptamine (5-HT), platelet-derived growth factor, and endothelin-1. Importantly, Nur77 was also significantly increased in lungs of rats with monocrotaline-induced PAH. Furthermore, we demonstrated that 5-HT markedly up-regulated Nur77 expression through the mitogen-activated protein kinases/extracellular signal-regulated kinase 1/2 pathway. Overexpression of Nur77 inhibited 5-HT-induced PASMC proliferation, as well as the expression of cyclin D1 and proliferating cell nuclear antigen. Mechanistically, we demonstrated that Nur77 specifically interacts with signal transducer and activator of transcription 3, thus inhibiting its phosphorylation and expression of its target genes, such as Pim-1, nuclear factor of activated T cells c2, and survivin in PASMCs. These results indicate that Nur77 is a novel negative-feedback regulator of PASMC proliferation through inhibition of the signal transducer and activator of transcription 3/Pim-1/nuclear factor of activated T cells axis. Modulation of Nur77 activity may potentially represent a novel therapeutic strategy for the treatment of PAH.
authors.affiliation: 1 Department of Pharmacy, Xinhua Hospital, Shanghai Jiaotong University, Shanghai, China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Liu
authors.forename: Jian
authors.initials: J
authors.lastname: Zhang
authors.forename: Bing
authors.initials: B
authors.lastname: Yi
authors.forename: Ming
authors.initials: M
authors.lastname: Chen
authors.forename: Jia
authors.initials: J
authors.lastname: Qi
authors.forename: You
authors.initials: Y
authors.lastname: Yin
authors.forename: Xiaotong
authors.initials: X
authors.lastname: Lu
authors.forename: Jean-Francois
authors.initials: JF
authors.lastname: Jasmin
authors.forename: Jianxin
authors.initials: J
authors.lastname: Sun
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000235:genetics; D049109:Cell Proliferation; D065627:Familial Primary Pulmonary Hypertension; D006976:Hypertension, Pulmonary / Q000235:genetics / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000378:metabolism*; D050778:NFATC Transcription Factors / Q000378:metabolism*; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1 / Q000378:metabolism*; D051573:Proto-Oncogene Proteins c-pim-1 / Q000378:metabolism*; D011651:Pulmonary Artery / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction; D015854:Up-Regulation / Q000502:physiology
chemical_list: D050778:NFATC Transcription Factors; C539820:Nr4a1 protein, rat; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D050796:STAT3 Transcription Factor; D051573:Proto-Oncogene Proteins c-pim-1
references.citation: Am J Physiol Lung Cell Mol Physiol. 2011 Mar;300(3):L486-97
references.pmid: 21186266
references.citation: Am J Respir Cell Mol Biol. 2011 Apr;44(4):548-55
references.pmid: 20558776
references.citation: Respir Physiol Neurobiol. 2006 May;152(1):83-91
references.pmid: 16125475
references.citation: Curr Opin Pharmacol. 2009 Jun;9(3):281-6
references.pmid: 19286424
references.citation: Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):2002-7
references.pmid: 14525795
references.citation: Am J Respir Crit Care Med. 2008 Jul 1;178(1):81-8
references.pmid: 18420966
references.citation: Microvasc Res. 2004 Sep;68(2):75-103
references.pmid: 15313118
references.citation: Arterioscler Thromb Vasc Biol. 2007 May;27(5):1072-8
references.pmid: 17347486
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11418-23
references.pmid: 17596340
references.citation: Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1798-809
references.pmid: 21890685
references.citation: Circulation. 2000 Feb 8;101(5):558-69
references.pmid: 10662755
references.citation: Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2528-34
references.pmid: 16399861
references.citation: J Neurochem. 2010 Feb;112(4):1065-73
references.pmid: 19968756
references.citation: Circ Res. 2009 Mar 27;104(6):742-9
references.pmid: 19213954
references.citation: Circ Res. 2006 Apr 14;98(7):931-8
references.pmid: 16527989
references.citation: Circulation. 2007 Jan 30;115(4):493-500
references.pmid: 17242285
references.citation: Br J Pharmacol. 2008 Oct;155(4):455-62
references.pmid: 18536742
references.citation: Exp Mol Med. 2005 Oct 31;37(5):466-75
references.pmid: 16264271
references.citation: J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):13S-24S
references.pmid: 15194174
references.citation: Mol Pharmacol. 2008 Oct;74(4):1046-58
references.pmid: 18577687
references.citation: Physiol Genomics. 2006 Jun 16;26(1):68-75
references.pmid: 16569776
references.citation: Biochem J. 2005 Sep 15;390(Pt 3):749-59
references.pmid: 15910281
references.citation: Clin Cancer Res. 2012 Jun 15;18(12):3223-8
references.pmid: 22566377
references.citation: Semin Respir Crit Care Med. 2005 Aug;26(4):402-8
references.pmid: 16121317
references.citation: Mol Cell Biol. 2006 Jul;26(13):4934-48
references.pmid: 16782881
references.citation: Biochem J. 2012 May 15;444(1):105-14
references.pmid: 22360269
references.citation: Circulation. 2011 Mar 22;123(11):1205-15
references.pmid: 21382889
references.citation: Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2114-24
references.pmid: 21680901
references.citation: Cardiovasc Res. 2013 Jul 1;99(1):185-93
references.pmid: 23554459
references.citation: Circulation. 2000 Nov 28;102(22):2781-91
references.pmid: 11094047
references.citation: FASEB J. 2007 Sep;21(11):2725-34
references.pmid: 17504974
references.citation: Carcinogenesis. 2004 Aug;25(8):1467-75
references.pmid: 15016657
references.citation: J Biol Chem. 2004 Nov 26;279(48):50097-101
references.pmid: 15448159
references.citation: Circ Res. 2012 Feb 3;110(3):428-38
references.pmid: 22194623
references.citation: J Mol Med (Berl). 2011 Nov;89(11):1089-101
references.pmid: 21761156
references.citation: J Gen Virol. 1999 Dec;80 ( Pt 12):3073-3081
references.pmid: 10567637
references.citation: Cell. 2004 Feb 20;116(4):527-40
references.pmid: 14980220
references.citation: J Immunol. 2002 Mar 15;168(6):2979-87
references.pmid: 11884470
references.citation: J Exp Med. 2011 Mar 14;208(3):535-48
references.pmid: 21321078
references.citation: Circulation. 2002 Sep 17;106(12):1530-5
references.pmid: 12234960
references.citation: Circ Res. 2004 May 14;94(9):1263-70
references.pmid: 15059929
references.citation: J Biol Chem. 2006 Nov 3;281(44):33467-76
references.pmid: 16945922
references.citation: Cardiovasc Res. 2005 Feb 15;65(3):609-18
references.pmid: 15664387
references.citation: J Exp Med. 2006 Mar 20;203(3):719-29
references.pmid: 16520388
references.citation: Cardiovasc Res. 2010 Feb 1;85(3):593-603
references.pmid: 19736308
references.citation: Circulation. 2004 Sep 14;110(11):1499-506
references.pmid: 15353500
references.citation: Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1535-41
references.pmid: 20631354